-
In Israel, air raid sirens spark anxiety and dilemmas
-
Iran accuses US of plotting ground attack despite diplomatic talk
-
Vingegaard clinches Tour of Catalonia victory
-
Despondent Verstappen questions Formula One future
-
Two more arrests over attempted attack on US bank HQ in Paris
-
Nepal's ex-PM attends court hearing in protest crackdown case
-
Iran parliament speaker says US planning ground attack
-
Despondent Verstappen says Red Bull woes 'not sustainable'
-
Piastri says Japan second place 'as good as a win' for McLaren
-
Nepal's former energy minister arrested in graft probe
-
IOC reinstating gender tests 'a disrespect for women' - Semenya
-
Youngest F1 title leader Antonelli to keep 'raising bar' after Japan win
-
High hopes at China's gateway to North Korea as trains resume
-
Antonelli wins in Japan to become youngest F1 championship leader
-
Mercedes' Antonelli wins Japanese Grand Prix to take lead
-
Germany's WWII munitions a toxic legacy on Baltic Sea floor
-
Iran claims aluminium plant attacks in Gulf as Houthis join war
-
North Korea's Kim oversees test of high-thrust engine: state media
-
Five Apple anecdotes as iPhone maker marks 50 years
-
'Excited' Buttler rejuvenated for IPL after horror T20 World Cup
-
Ship insurers juggle war risks for perilous Gulf route
-
Helplines buzz with alerts from seafarers trapped in war
-
Let's get physical: Singapore's seniors turn to parkour
-
Indian tile makers feel heat of Mideast war energy crunch
-
At 50, Apple confronts its next big challenge: AI
-
Houthis missile attacks on Israel widen Middle East war
-
Massive protests against Trump across US on 'No Kings' day
-
Struggling Force lament missed opportunities after Chiefs defeat
-
US thrashed 5-2 by Belgium in reality check for World Cup hosts
-
China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
-
Lakers guard Doncic gets one-game ban for accumulated technicals
-
Houthis claim missile attacks on Israel, entering Middle East war
-
NBA Spurs stretch win streak to eight in rout of Bucks
-
US lose 5-2 to Belgium in rude awakening for World Cup hosts
-
Sabalenka sinks Gauff to win second straight Miami Open title
-
Lebanon kids struggle to keep up studies as war slams school doors shut
-
Cherry blossoms, kite-flying and 'No Kings' converge on Washington
-
Britain's Kerr to target El Guerrouj's mile world record
-
Sailboats carrying aid reach Cuba after going missing: AFP journalist
-
Pakistan to host Saudi, Turkey, Egypt for talks on Mideast war
-
Formidable Sinner faces Lehecka for second Miami Open title
-
Tuchel plays down Maguire's World Cup hopes
-
'Risky moment': Ukraine treads tightrope with Gulf arms deals
-
Japan strike late to win Scotland friendly
-
India great Ashwin joining San Francisco T20 franchise
-
Israel hits Iran naval research site, fresh blasts rattle Tehran
-
Kohli fires Bengaluru to big win after IPL remembers stampede dead
-
Graou shines as Toulouse sink Montpellier, Pau climb to second in Top 14
-
Vingegaard nears Tour of Catalonia victory with stage six win
-
Malinin bounces back from Olympic meltdown with third straight world skating gold
Coalition of states vows to protect access to abortion pill under Trump review
A coalition of attorneys general across states including New York, Minnesota and Arizona vowed Monday to protect access to mifepristone, the medication used in the majority of abortions in the United States.
The move comes as the Trump administration has reportedly launched a review into the medication's safety, in what many abortion rights' organizations have dubbed a blatant attempt to undermine health care access.
"The decision to reexamine access to this medication was made in response to a scientifically baseless letter and ignores decades of research that prove mifepristone is safe and effective," read the joint statement that included New York's Attorney General Letitia James, who co-led the coalition of 20 officials in the effort.
"Medical decisions should be left between patients, their families, and their providers – and they should be guided by science, not political agendas," the statement continued.
"If access to mifepristone is challenged, we will take action to protect it," it added.
Officials who co-signed the initiative represented Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, Oregon, Rhode Island, Vermont, Washington state, and the District of Columbia.
Trump's health chief Robert F. Kennedy Jr and FDA Commissioner Marty Makary reportedly delivered a letter to 22 Republican attorneys general saying that the FDA was conducting its own review of the pill.
Proponents of reviewing mifepristone's safety have cited a study -- which was not peer-reviewed and published on a website, not in a scientific journal -- conducted by a conservative think-tank.
The Ethics & Public Policy Center (EPPC) says its priorities include "pushing back against the extreme progressive agenda while building a consensus for conservatives."
The medication has been used for 25 years in the United States. It is the most common method for abortion care and also routinely used for managing early miscarriage.
Mifepristone, which prevents pregnancy progression, and misoprostol, which empties the uterus, are approved to terminate a pregnancy up to 70 days of gestation in the United States.
A.Williams--AT